Aging and chronic ailments like diabetes decrease the ability of the kidneys to recover from injuries, resulting in chronic kidney disease (CKD)
By July 31, 2025, the FDA received 605 reports of adverse events that occurred after patients used compounded semaglutide
final data from Phase 3 clinical trials has yet to be released
Yang F, Wang X, Qi J, Zhang K, Jiang Y, Feng B, et al
The American Diabetes Association (ADA) Standards of Care 2019 recommend diligent monitoring and avoidance of hypoglycemic events in older adults with T2D, stating that hypoglycemia should be assessed and managed by adjusting glycemic targets and pharmacologic interventions, adding that in older adults at increased risk of hypoglycemia, medication classes with low risk of hypoglycemia are preferred [27]
I really need to have answers